SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-23-004868
Filing Date
2023-02-28
Accepted
2023-02-28 12:23:21
Documents
1
Period of Report
2022-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 7619
  Complete submission text file 0001437749-23-004868.txt   8950
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38079 | Film No.: 23681764

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations